given what's on the horizon from the published phase ii clinical trials for syni drug two weeks ago, syni could be on its way to being a $25-$50 stock with only 2.6 mil outstanding and 2 million float.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.